WSGR logoWSGR logo
Davelyn Couch
Associate
Corporate
Palo Alto

D650-849-3445

Download vCard
Open PDF

Davelyn Couch is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s corporate group.

Prior to law school, Davelyn worked as a tax associate at PricewaterhouseCoopers LLP. There, she assisted clients in interpreting and complying with the requirements of state and local tax authorities. She is a certified public accountant in California.

Experience

Davelyn Couch is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s corporate group.

Prior to law school, Davelyn worked as a tax associate at PricewaterhouseCoopers LLP. There, she assisted clients in interpreting and complying with the requirements of state and local tax authorities. She is a certified public accountant in California.

Focus Areas
Recent Insights
Client Highlights
Wilson Sonsini Advises Circle Pharma on $90 Million Series D
On September 3, 2024, Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, announced the successful closing of a $90 million Series D financing round, which includes the conversion of a convertible note. The financing was led by The Column Group with participation from new and existing investors, including Nextech Invest and Euclidean Capital. The proceeds from the financing will be used to fund the clinical development of CID-078, Circle Pharma’s first-and-only-in-class cyclin A/B RxL inhibitor, and to support the development of the company’s portfolio of discovery programs built with its MXMO macrocycle platform.
Learn More
Client Highlights
Wilson Sonsini Advises Digestiva on $18.4 Million Series A Financing
On July 15, 2024, Digestiva, a leading food biotech company, successfully closed its Series A equity financing round, raising $18.4 million. The round was led by Magdalena, a global leader in sugar cane processing, with participation from UC Investments, and existing investors The March Fund and Astanor. Digestiva's groundbreaking enzyme technology platform was initially discovered by co-founder Dr. Wilson Mak, in the lab of UC Davis faculty member Dr. Justin Siegel, a global leader in enzyme discovery, development, and design. Wilson Sonsini Goodrich & Rosati represented Digestiva in the transaction.
Learn More
View All
WSGR logo
Copyright © 2024 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.